Trenton, April 6, 2026 ― Last week, HINJ released a statement addressing proposed federal tariffs on pharmaceuticals and key materials. The statement was referenced in several New Jersey media outlets over the weekend.
- BINJE: Buteas, Hart: Trump’s latest tariff will hurt sector Leaders of HINJ, BioNJ say executive order — calling for tariffs as high as 100 percent — will not achieve goal of lowering prices, creating more manufacturing in U.S.
- NJBIZ: Trump 100% pharma tariffs raise concerns for New Jersey life sciences Trump administration to impose up to 100% tariffs on imported patented drugs, key ingredients; New Jersey life sciences leaders warn tariffs could raise costs, hinder innovation
- NJ Business Magazine: Trump Imposes 100% Tariffs on Pharmaceuticals, Adjusts Duties on Steel and Metals